UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 重度または持続性子宮出血のマネージメントmanaging an episode of severe or prolonged uterine bleeding [show details]
…emergency department are discussed separately. There is no standard definition of acute uterine bleeding. Acute uterine bleeding has been described as excessively heavy or prolonged bleeding of uterine origin …
2. 腟出血をきたす成人女性への救急外来での対処法approach to the adult with vaginal bleeding in the emergency department [show details]
…devices designed to control postpartum hemorrhage (eg, Bakri Balloon) may be used for acute, profuse uterine bleeding in nonpregnant patients. If such a device is unavailable, a bladder (Foley) catheter may…
3. 産褥期の概要：生理学的変化、合併症、母体のケアoverview of the postpartum period physiology complications and maternal care [show details]
4. 婦人科疾患のマネージメントにおけるインターベンショナルラジオロジーinterventional radiology in management of gynecological disorders [show details]
…surgery for controlling acute uterine hemorrhage . Most such cases involve postpartum hemorrhage , but the discussion below also applies to gynecological causes of acute uterine hemorrhage. In addition, PTE…
5. 子宮平滑筋腫（子宮筋腫）：疫学、臨床的特徴、診断、自然経過uterine leiomyomas fibroids epidemiology clinical features diagnosis and natural history [show details]

English Journal

Laparoscopic Compared With Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess.

Shigemi D, Matsui H, Fushimi K, Yasunaga H.
Obstetrics and gynecology. 2019 Jun;133(6)1224-1230.
To compare operative outcomes of laparoscopic surgery compared with laparotomy in patients with moderate to severe pelvic inflammatory disease (PID). Using the Diagnosis Procedure Combination database, a national inpatient database for acute-care inpatients in Japan, we performed a large, nationwide
PMID 31135738

Laparoscopic Compared With Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess.

Shigemi D, Matsui H, Fushimi K, Yasunaga H.
Obstetrics and gynecology. 2019 May;().
To compare operative outcomes of laparoscopic surgery compared with laparotomy in patients with moderate to severe pelvic inflammatory disease (PID). Using the Diagnosis Procedure Combination database, a national inpatient database for acute-care inpatients in Japan, we performed a large, nationwide
PMID 31083118

The predictive role of CA-125 in the management of tubo-ovarian abscess. A retrospective study.

Levin G, Herzberg S, Dior UP, Shushan A, Gilad R, Benshushan A, Rottenstreich A.
European journal of obstetrics, gynecology, and reproductive biology. 2019 May;238()20-24.
Tubo-ovarian abscess (TOA) is a well-established sequel of acute pelvic inflammatory disease (PID). While as up to 25% of women will experience conservative treatment failure, the factors associated with treatment failure are not clearly-established, and the role of Cancer antigen 125 (CA-125) is un
PMID 31082739

林保良,岩田嘉行
The Japanese Journal of Antibiotics 42(10), 2082-2089, 1989
Cefodizime (THR-221, CDZM) について婦人科領域における基礎的, 臨床的検討を行い次の成績を得た。 1. 子宮組織内及び骨盤死腔液中移行 CDZM1gを60分点滴静注後摘出した子宮各組織内濃度及びCDZM2gを20分点滴静注後の骨盤死腔液中濃度は婦人科領域感染症から検出頻度の高いグラム陰性桿菌, 嫌気性菌の発育を阻止するに十分な濃度であっ …
NAID 130004394886

小幡功,今川信行,小池清彦,大和竜夫,林茂興,林茂一郎
ＣＨＥＭＯＴＨＥＲＡＰＹ 37(Supplement1), 579-587, 1989
7432-Sの子宮継織及び子宮附綱器組織への移行性と産婦人科領域感染症に対する有用性と安全性を検討し, 次の結果を得た。 L7432-S 100mgを1回経口投与により子宮組織及び子宮附属器組織はCmax1.13～1.84μg/g, Tmax3.34～3.57hrと経口剤としては良好な移行性が認められた。 2. 本剤投与により産婦人科感染症21例は全例が総合的効 …
NAID 130004196814

小幡功,今川信行,小池清彦,森本紀,蜂屋祥一,林茂一郎,林茂興,大和竜夫
ＣＨＥＭＯＴＨＥＲＡＰＹ 35(Supplement1), 1196-1209, 1987
6315-S (Flomoxef) の子宮および子宮附属器組織, 骨盤死腔浸出液への移行性と産婦人科領域感染症に対する有用性と安全性を検討し, 次の結果を得た。 1. 6315-S 1g one shot 静注投与により子宮組織および子宮附属器組織はCmax 16.7～34.35μg/g, Tmax 0.13～0.45時間と良好な移行性が認められた。 2. 骨盤 …
NAID 130004195657